Format

Send to

Choose Destination
Nat Commun. 2015 Jul 14;6:7722. doi: 10.1038/ncomms8722.

The key role of the scaffold on the efficiency of dendrimer nanodrugs.

Author information

1
1] Laboratoire de Chimie de Coordination du CNRS, UPR 8241, 205 route de Narbonne, BP 44099, 31077 Toulouse Cedex 4, France [2] Université de Toulouse, UPS, INP, LCC, F-31077 Toulouse, France.
2
1] Centre de Physiopathologie de Toulouse Purpan, F-31300 Toulouse, France [2] INSERM, U1043; CNRS, U5282; Université de Toulouse, UPS, Toulouse, France.
3
1] Centre de Recherche en Cancérologie de Toulouse, F-31300 Toulouse, France [2] INSERM, U1037; CNRS, U5294; Université de Toulouse, UPS, Toulouse, France.
4
Department of Innovative Technologies, University of Applied Sciences and Arts of Southern Switzerland, Galleria 2, 6928 Manno, Switzerland.
5
Faculty of Science, J.E. Purkinje University, Ceske mladeze 8, 400 96 Ústí nad Labem, Czech Republic.
6
Kazan State Architect and Civil Engineering University, Zelenaya 1, Kazan 420043, Russia.
7
A.E. Arbuzov Institute of Organic and Physical Chemistry of Kazan Scientific Center of Russian Academy of Science, Arbuzov Str., 8, Kazan 420088, Russia.

Abstract

Dendrimers are well-defined macromolecules whose highly branched structure is reminiscent of many natural structures, such as trees, dendritic cells, neurons or the networks of kidneys and lungs. Nature has privileged such branched structures for increasing the efficiency of exchanges with the external medium; thus, the whole structure is of pivotal importance for these natural networks. On the contrary, it is generally believed that the properties of dendrimers are essentially related to their terminal groups, and that the internal structure plays the minor role of an 'innocent' scaffold. Here we show that such an assertion is misleading, using convergent information from biological data (human monocytes activation) and all-atom molecular dynamics simulations on seven families of dendrimers (13 compounds) that we have synthesized, possessing identical terminal groups, but different internal structures. This work demonstrates that the scaffold of nanodrugs strongly influences their properties, somewhat reminiscent of the backbone of proteins.

PMID:
26169490
PMCID:
PMC4510975
DOI:
10.1038/ncomms8722
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center